Rezultati - Rahul Aggarwal
- Showing 1 - 20 results of 59
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms od James C. Yao, Emily K. Bergsland, Rahul Aggarwal, Ana M. Aparicio, Himisha Beltran, Judy S. Crabtree, Christine L. Hann, Toni Ibrahim, Lauren A. Byers, Hironobu Sasano, John Umejiego, Marianne Pavel
Izdano 2022Revisão -
13
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer od Thomas A. Hope, Rahul Aggarwal, Bryant H. Chee, Dora Tao, Kirsten L. Greene, Matthew R. Cooperberg, Felix Feng, Albert J. Chang, Charles J. Ryan, Eric J. Small, Peter R. Carroll
Izdano 2017Artigo -
14
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer od Emerson A. Lim, Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley, Edward F. Attiyeh, James Greger, Shujian Wu, Pharavee Jaiprasart, John T. Loffredo, Nibedita Bandyopadhyay, Hong Xie, Aaron R. Hansen
Izdano 2023Artigo -
15
Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer od Vadim S. Koshkin, Vipul Kumar, Brad Kline, Domenique Escobar, Maya Aslam, Matthew R. Cooperberg, Rahul Aggarwal, Ivan de Kouchkovsky, Jonathan Chou, Maxwell V. Meng, Terence W. Friedlander, Sima P. Porten, Thomas A. Hope
Izdano 2024Artigo -
16
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies od Rahul Aggarwal, Scott Thomas, Nela Pawłowska, Imke H. Bartelink, Jennifer A. Grabowsky, Thierry Jahan, Amy Cripps, Armand Harb, Jim Leng, Anne Reinert, Ilaria Mastroserio, Thach-Giao Truong, Charles J. Ryan, Pamela N. Münster
Izdano 2017Artigo -
17
Potential global impact of <scp>sodium–glucose</scp> cotransporter‐2 inhibitors in heart failure od Khawaja M. Talha, Javed Butler, Stephen J. Greene, Rahul Aggarwal, Stefan D. Anker, Brian Claggett, Kieran F. Docherty, Scott D. Solomon, John J.V. McMurray, James L. Januzzi, Muthiah Vaduganathan, Gregg C. Fonarow
Izdano 2023Artigo -
18
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants od Rahul Aggarwal, Christian T. Ruff, Saverio Virdone, Sylvie Perreault, Ajay K. Kakkar, Michael G. Palazzolo, Marc Dorais, Gloria Kayani, Daniel E. Singer, Eric A. Secemsky, Jonathan P. Piccini, Usman A. Tahir, Changyu Shen, Robert W. Yeh
Izdano 2023Artigo -
19
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial od Rahul Aggarwal, Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Richard L. Dunbar, Steven B. Ketchum, Jean‐Claude Tardif, F M A C Martens, Christie M. Ballantyne, Michael Szarek, R. Preston Mason
Izdano 2025Artigo -
20
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer od Janice M. Mehnert, Andréa Varga, Marcia S. Brose, Rahul Aggarwal, Chia‐Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A. Piha‐Paul, Jill Gilbert, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam
Izdano 2019Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cancer
Prostate cancer
Oncology
Biology
Cancer research
Gene
Genetics
Prostate
Androgen receptor
Gene expression
Immunotherapy
Pathology
Biochemistry
Clinical trial
Adverse effect
Bioinformatics
Chemistry
Cohort
Disease
Enzalutamide
Gastroenterology
Clinical endpoint
Confidence interval
DNA methylation
Epigenetics
Genome
Immunology
Mutation